(MENAFN- PR Newswire) MY01 Inc. receives their first-ever "Breakthrough Device" designation by the FDA in October, joining a select list of Orthopaedic companies to receive this designation since the ...
MY01 provides the necessary immediate and timely information (1) to aid physicians in monitoring patients at-risk of developing Compartment Syndrome.(2) MONTREAL, May 6, 2021 /CNW/ - MY01 Inc. is on a ...
MONTREAL, June 13, 2022 /PRNewswire/ - MY01 Inc. today announced that initial data from an ongoing, prospective multi-center study was presented at the Canadian Orthopaedic Association's Annual ...
MONTREAL, Sept. 12, 2023 /PRNewswire/ - MY01, Inc., a pioneering company dedicated to revolutionizing the diagnosis of compartment syndrome, today announced it has achieved a milestone of serving 1000 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results